You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Chartwell Molecular Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?

CHARTWELL MOLECULAR has eighty-eight approved drugs.

There are two tentative approvals on CHARTWELL MOLECULAR drugs.

Summary for Chartwell Molecular

US Patents:	0
Tradenames:	76
Ingredients:	74
NDAs:	88

Drugs and US Patents for Chartwell Molecular

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecular	PREDNISOLONE	prednisolone	TABLET;ORAL	080531-002	Approved Prior to Jan 1, 1982	BX	RX	No	No		⤷ Sign Up				⤷ Sign Up
Chartwell Molecular	DIPHENYLAN SODIUM	phenytoin sodium	CAPSULE;ORAL	080857-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Chartwell Molecular	ACETAZOLAMIDE	acetazolamide	TABLET;ORAL	084840-001	Approved Prior to Jan 1, 1982	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Chartwell Molecular	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	TABLET;ORAL	080949-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Chartwell Molecular	DIAZEPAM	diazepam	SOLUTION;ORAL	206477-001	Jun 24, 2016	AA	RX	No	No		⤷ Sign Up				⤷ Sign Up
Chartwell Molecular	OLANZAPINE	olanzapine	TABLET;ORAL	203333-006	Mar 15, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Chartwell Molecular	CLOBAZAM	clobazam	TABLET;ORAL	212092-001	Oct 30, 2019		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Chartwell Molecular

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chartwell Molecular	MYKROX	metolazone	TABLET;ORAL	019532-001	Oct 30, 1987	4,517,179	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.